参考文献/References:
[1] Zene Q S,Liu H P,Zhang K,et a1.Noninvasive evaluation of cere-bral glioma grade by using multivoxel 3D proton MR spectroscopy[J].Magn Reson Imaging,2011,29(1):25-31.
[2] Bai X,Zhang Y T,Liu Y,et al.Grading of supratentorial astrocytic tumors by using the difference of ADC value[J].Neuroradiology,2011,53(7):533-539.
[3] Server A,Kulle B,Gadmar ?B,et al.Measurements of diagnostic examination performance using quantitative apparent diffusion coefficient and proton M R spectroscopic imaging in the preoperative evaluation of tumor grade in cerebral gliomas[J].Eur J Radiol,2011,80(2):462-470.
[4] Arvinda HR,Kesavadas C,Sarma PS,et al.Glioma grading:sensi-tivity,specificity,positive and negative predictive values of diffu-sion and perfusion imaging[J].J Neurooncol,2009,94(1):87-96.
[5] Saitta L,Heese O,F?rster AF,et al.Signal intensity in T2’ magnetic resonance imaging is related to brain glioma grade[J].Eur Radiol,2011,21(5):1068-1076.
[6] Padma MV,Said S,Jacobs M,et al.Prediction of pathology and survival by FDG PET in gliomas[J].J Neurooneol,2003,64(3):227-237.
[7] 程勋全,钱立庭.PET/CT显像剂在脑胶质瘤中的应用研究进展[J].中国实验诊断学,2009,13(9):1308-1310.
[8] 蔡莉,李彦生.氟代脱氧葡萄糖与氨基酸PET在脑肿瘤中的对比研究[J].国外医学:放射医学核医学分册,2005,29(1):10-14.
[9] 韩志铁,苏少波,雪亮,等.11C-METPET与MRI影像融合技术在胶质瘤术前评价和术中导航中的应用价值[J].中国现代神经疾病杂志,2013,13(4):324-329.
[10] P?pperl G,Kreth FW,Mehrkens JH,et al.FET PET for the evalua-tion of untreated gliomas:correlation of FET uptake and uptake kinetics with tumor grading[J].Eur J Nucl Med Mol Imaging,2007,34(12):1933-1942.
[11] Mertens K,Acou M,Van Hauwe J,et al.Validation of 18F-FDG PET at conventional and delayed intervals for the discrimination of high-grade from low-grade gliomas:a stereotactic PET and MRI study[J].Clin Nucl Med,2013,38(7):495-500.
[12] Holodny AI,Makeyev S,Beattie BJ,et al.Apparent diffusion coef-ficient of glial neoplasms:correlation with fluorodeoxyglucose-e-mission tomography and gadolinium-enhanced MR imaging[J].AJNR A m J Neurodiol,2010,31(6):1042-1048.
[13] Gempt J,Soehngen E,Forster S,et al.Multimodal imaging in cere-bral gliomas and its neuropathological correlation[J].Eur J Radi-ol,2014,83(5):829-834.
[14] Rahm V,Boxheimer L,Bruehlmeier M,et al.Focal changes in dif-fusivity on apparent diffusion coefficient MR imaging and amino acid uptake on PET do not colocalize in nonenhancing low-gradegliomas[J].J Nucl Med,2014,55(4):546-550.
[15] Kelly PJ,Daumas-Duport C,Scheithauer BW,et al.Stereotactic histologic correlations of computed tomography-and magnetic reso-nance imaging-defined abnormalities in patients with glial neo-plasms[J].Mayo Clin Proc,1987,62(6):450-459.
[16] Pauleit D,Floeth F,Hamacher K,et al.O-(2-18F-fluoroethy)-L-ty-rosine PET combined with MRI improves the diagnostic assessment of cerebral gliomas[J].Brain,2005,128(pt3):678-687.
[17] Tanaka Y,Nariai T,Momose T,et al.Glioma surgery using a multi-modal navigation system with integrated metabolic images[J].J Neurosurg,2009,110(1):163-172.
[18] Miwa K,Shinoda J,Yano H,et al.Discrepancy between lesion dis-tributions on methionine PET and M R images in patients with glioblastoma multiforme:insight from a PET and MR fusion image study[J].J Neurol Neurosury Psychiatry,2004,75(10):1457-1462.
[19] 郭旭,郭毅,程欣,等.PET-MRI影像融合技术在胶质瘤的活组织检查和手术中的应用[J].中华医学杂志,2013,93(1):15-18.
[20] 邓美玲,吴少雄,黄绍敏,等.11C-MET PET和MRI对脑高级别神经胶质瘤术后放疗靶区设定的比较研究[J].中华放射肿瘤学杂志,2010,19(5):415-419.
[21] Braun V,Dempf S,Weller R,et al.Cranial neuronavigation with di-rect integration of 11C methionine positron emission tomography(PET) data-results of a pilot study in 32 surgical cases[J].Acta Neurochir(Wien),2002,144(8):777-782.
[22] Pirotte B,Goldman S,Massager N,et al.Combined use of [F-18] fluorodeoxyglucose and[C-11] methionine in 45 PET-guided stereo-tactic brain biopsies[J].J Neurosurg,2004,101(3):476-483.
[23] Pirotte B,Goldman S,Massager N,et al.Comparison of 18F-FDG and 11C-methionine for PET-guided stereotactic brain biopsy in gliomas[J].J Nucl Med,2004,45(8):1293-1298.
[24] Navarria P,Reggionri G,Pessina F,et al.Investigation on the role of integratea PET/MRI ior target volume definition and radiothera-py planning in patients with high grade glioma[J].Radiother Oncol,2014,112(3):425-429.
[25] Filss CP,Stoffels G,Galldiks N,et al.Histogram analysis reveals a better delineation of tumor volume from background in 18F-FET PET compared to CBV maps in a hybrid PET-MR studie in gliomas[J].Nucl Instrum Methods Phy Res A,2014,734:175-178.
[26] Rieken S,Habermehl D,Giesel FL,et al.Analysis of FET-PET imaging for target volume definition in patients with gliomas treated with conformal radiotherapy[J].Radiother Oncol,2013,109(3):487-492.
[27] Chao ST,Suh JH,Raja S,el al.The sensitivity and specificity of FDG PET in distinguishing recurrent brain tumor from radionecro-sis in patients treated with stereotactic radiosurgery[J].Int J Cancer,2001,96(3):191-197.
[28] Imani F,Boada FE,Lieberman FS,et al.Molecular and metabolic pattern classification for detection of brain glioma progression[J/OL].Eur J Radiol,2014,83(2):e100-105.[2014-11-10].http://www.sciencedirect.com/science/article/pii/S0720048X13005901.
[29] Chung JK,Kim YK,Kim SK,et al.Usefulness of 11C-methionine PET in the evaluation of brain lesions that are hypo-or isometabolic on 18F-FDG PET[J].Eur J Nucl Med Mol Imaging,2002,29(2):176-182.
[30] Chen W.Clinical applications of PET in brain tumors[J].J Nucl Med,2007,48(9):1468-1481.
[31] D,Souza MM,Sharma R,Jaimini A,et al.11C-MET PET/CT and advanced MRI in the evaluation of tumor recurrence in high-grade gliomas[J].Clin Nucl Med,2014,39(9):791-798.
[32] Grosu AL,Weber WA,Riedel E,et al.L-(methyl)11C-methionine positron emission tomography for target delineation in resected highgrade gliomas before radiotherapy[J].Int J Radiat Oncol Biol Phys,2005,63(1):64-74.
[33] Galldiks N,Stoffels G,Ruge MI,et al.Role of O-(2-18F-Fluo-roethyl)-L-tyrosine PET as a diagnostic tool for detection of mali-gant progression in patients with low-grade glioma[J].J Nucl Med,2013,54(12):2046-2054.
[34] Jansen NL,Schwartz C,Graute V A,et al.Prediction of oligoden-droglial histology and LOH 1p/19q using dynamic[18F] FET-PETimaging in intracranial W H O grade Ⅱ and Ⅲ gliomas[J].NeuroOncol,2012,14(12):1473-1480.
[35] Niyazi M,Jansen N,Ganswindt U,et al.Re-irradiation in recurrent malignant glioma:prognostic value of[18F] FET-PET[J].J Neuroon-col,2012,110(3):389-395.
[36] Galldiks N,Rapp M,Stoffels G,et al.Response assessment of beva-cizumab inpatients with recurrent malignant glioma using[18F] Fluo-roethyl-1-tyrosine PET in comparison to MRI[J].Eur J Nucl Med Mol Imaging,2013,40(1):22-33.
相似文献/References:
[1]何燕,苏晋,郑晓霞,等.P-糖蛋白抑制剂在PET显像中的应用研究[J].国际放射医学核医学杂志,2016,40(1):1.[doi:10.3760/cma.j.issn.1673-4114.2016.01.001]
He Yan,Su Jin,ZhengXiaoxia,et al.Developing P-glycoprotein inhibitor marked by PET[J].International Journal of Radiation Medicine and Nuclear Medicine,2016,40(1):1.[doi:10.3760/cma.j.issn.1673-4114.2016.01.001]
[2]许飞,刘建军,黄钢,等.PET乏氧显像在预测肿瘤乏氧及指导临床治疗中的应用进展[J].国际放射医学核医学杂志,2016,40(1):35.[doi:10.3760/cma.j.issn.1673-4114.2016.01.008]
Xu Fei,Liu Jianjun,Huang Gang,et al.The application of hypoxia imaging with PET in predicting tumor hypoxia and guiding clinical therapy[J].International Journal of Radiation Medicine and Nuclear Medicine,2016,40(1):35.[doi:10.3760/cma.j.issn.1673-4114.2016.01.008]
[3]胡伟,赵军.小胶质细胞在AD炎性机制中的作用及其常见PET显像剂的应用进展[J].国际放射医学核医学杂志,2016,40(1):44.[doi:10.3760/cma.j.issn.1673-4114.2016.01.009]
Hu Wei,Zhao Jun.Microglia’s Alzheimer disease inflammatory mechanisms and progress of its common application in PET imaging agents[J].International Journal of Radiation Medicine and Nuclear Medicine,2016,40(1):44.[doi:10.3760/cma.j.issn.1673-4114.2016.01.009]
[4]张莹莹,王振光,孔艳.PET/CT显像在肺间质纤维化中的应用进展[J].国际放射医学核医学杂志,2016,40(1):55.[doi:10.3760/cma.j.issn.1673-4114.2016.01.011]
Zhang Yingying,Wang Zhenguang,Kong Yan.Application advancement on PET/CT in pulmonary interstitial fibrosis[J].International Journal of Radiation Medicine and Nuclear Medicine,2016,40(1):55.[doi:10.3760/cma.j.issn.1673-4114.2016.01.011]
[5]李海峰,张晓军,李云钢,等.国产模块LOOP环改良法合成11C-蛋氨酸[J].国际放射医学核医学杂志,2016,40(2):106.[doi:10.3760/cma.j.issn.1673-4114.2016.02.004]
Li Haifeng,Zhang Xiaojun,Li Yungang,et al.Synthesis of 11C-methionine on home-made module by the improved LOOP method[J].International Journal of Radiation Medicine and Nuclear Medicine,2016,40(1):106.[doi:10.3760/cma.j.issn.1673-4114.2016.02.004]
[6]史文杰,孟召伟,谭建.基于Deauville标准探讨18F-FDG PET/CT在霍奇金淋巴瘤复发诊断中的应用价值[J].国际放射医学核医学杂志,2016,40(2):120.[doi:10.3760/cma.j.issn.1673-4114.2016.02.007]
Shi Wenjie,Meng Zhaowei,Tan Jian.Value of 18F-FDG PET/CT on diagnosis of Hodgkin lymphoma recurrence using Deauville criterion[J].International Journal of Radiation Medicine and Nuclear Medicine,2016,40(1):120.[doi:10.3760/cma.j.issn.1673-4114.2016.02.007]
[7]李海峰,张晓军,张锦明.多巴胺转运蛋白显像剂11C-β-CFT在帕金森病中的应用研究[J].国际放射医学核医学杂志,2016,40(3):218.[doi:10.3760/cma.j.issn.1673-4114.2016.03.011]
Li Haifeng,Zhang Xiaojun,Zhang Jinming.Review of the use of dopamine transporter imaging agent 11C-β-CFT for diagnosing Parkinson disease[J].International Journal of Radiation Medicine and Nuclear Medicine,2016,40(1):218.[doi:10.3760/cma.j.issn.1673-4114.2016.03.011]
[8]尤阳,轩昂,张杰,等.淋巴瘤患者大脑静息葡萄糖代谢改变[J].国际放射医学核医学杂志,2016,40(4):255.[doi:10.3760/cma.j.issn.1673-4114.2016.04.003]
You Yang,Xuan Ang,Zhang Jie,et al.Changes in resting-state brain glucose metabolism in patients with lymphoma[J].International Journal of Radiation Medicine and Nuclear Medicine,2016,40(1):255.[doi:10.3760/cma.j.issn.1673-4114.2016.04.003]
[9]王朋,崔邦平,代文莉,等.18F-FDG PET/CT在前列腺癌中的应用进展[J].国际放射医学核医学杂志,2016,40(4):277.[doi:10.3760/cma.j.issn.1673-4114.2016.04.008]
Wang Peng,Cui Bangping,Dai Wenli,et al.Progress in the application of 18F-FDG PET/CT in prostate cancer[J].International Journal of Radiation Medicine and Nuclear Medicine,2016,40(1):277.[doi:10.3760/cma.j.issn.1673-4114.2016.04.008]
[10]李菲,黄俊星,张俊.18F-FDG PET/CT在食管癌中的临床应用[J].国际放射医学核医学杂志,2016,40(4):282.[doi:10.3760/cma.j.issn.1673-4114.2016.04.009]
Li Fei,Huang Junxing,Zhang Jun.The clinical application of 18F-FDG PET/CT in esophageal cancer[J].International Journal of Radiation Medicine and Nuclear Medicine,2016,40(1):282.[doi:10.3760/cma.j.issn.1673-4114.2016.04.009]
[11]展凤麟,汪世存,潘博,等.11C-胆碱和18F-FDG PET/CT显像在脑胶质瘤诊断中的应用[J].国际放射医学核医学杂志,2013,37(4):193.[doi:10.3760/cma.j.issn.1673-4114.2013.04.001]
ZHAN Feng-lin,WANG Shi-cun,PAN Bo,et al.Application of 11C-choline and 18F-FDG PET/CT in diagnosing brain glioma[J].International Journal of Radiation Medicine and Nuclear Medicine,2013,37(1):193.[doi:10.3760/cma.j.issn.1673-4114.2013.04.001]
[12]乐亚丽,陈跃.多种不同PET或PET/CT分子探针在胶质瘤中的应用进展[J].国际放射医学核医学杂志,2013,37(6):364.[doi:10.3760/cma.j.issn.1673-4114.2013.06.010]
LE Ya-li,CHEN Yue.Progress on application of different PET or PET/CT agents in glioma[J].International Journal of Radiation Medicine and Nuclear Medicine,2013,37(1):364.[doi:10.3760/cma.j.issn.1673-4114.2013.06.010]
[13]孙娜,赵晋华,乔文礼.胶质瘤显像剂的研究与应用进展[J].国际放射医学核医学杂志,2011,35(6):330.[doi:10.3760,cma.j.issn.1673-4114.2011.06.003]
SUN Na,ZHAO Jin-hua,QIAO Wen-li.Advances in appUcafion of radiotracers for glioma imaging[J].International Journal of Radiation Medicine and Nuclear Medicine,2011,35(1):330.[doi:10.3760,cma.j.issn.1673-4114.2011.06.003]
[14]程林,程竞仪.氨基酸类正电子显像在胶质瘤中的研究进展[J].国际放射医学核医学杂志,2017,41(4):283.[doi:10.3760/cma.j.issn.1673-4114.2017.04.009]
Cheng Lin,Cheng Jingyi.Research progress on glioma imaging using amino acid PET[J].International Journal of Radiation Medicine and Nuclear Medicine,2017,41(1):283.[doi:10.3760/cma.j.issn.1673-4114.2017.04.009]